The Obama administration is on the defensive days before Iran nuclear negotiations are scheduled to resume in Geneva, as critics in Israel and in the U.S. Congress say Iran would concede too little and gain too much from an easing of international economic sanctions.
President Barack Obama received support from the chairman of the U.S. Senate intelligence committee in his efforts to dissuade lawmakers from imposing further sanctions on Iran amid international negotiations.
Teva Pharmaceutical Industries Ltd. agreed to pay Israel 2 billion shekels ($565 million) in taxes, joining fertilizer maker Israel Chemicals Ltd. in releasing profits accumulated since 2005 under a law designed to encourage investments.
Israeli Minister of Intelligence & Strategic Affairs Yuval Steinitz said the framework of talks with Iran has changed and that sanctions imposed on the country over its nuclear program could be completely lifted.
Israel’s benchmark government bonds rose, pushing the yield to a three-month low, after U.S. lawmakers agreed to raise the country’s debt limit and avert a default, increasing investors’ risk appetite.